ENT-MS-12 questionnaire: A novel tool to investigate otolaryngology symptoms in patients with relapsing-remitting multiple sclerosis. Results from a pilot study

3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing–remitting multiple sclerosis: A 3-year pilot study

Journal of the Neurological Sciences ◽

10.1016/j.jns.2010.07.014 ◽

2010 ◽

Vol 297 (1-2) ◽

pp. 76-81 ◽

Cited By ~ 20

Author(s):

Y. Zhang ◽

L.M. Metz ◽

V.W. Yong ◽

J.R. Mitchell

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Gray Matter ◽

Relapsing Remitting ◽

Deep Gray Matter ◽

Relapsing Remitting Multiple Sclerosis ◽

Over Time

Improvement of Driving Skills in Persons With Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2013.08.294 ◽

2014 ◽

Vol 95 (3) ◽

pp. 531-537 ◽

Cited By ~ 8

Author(s):

Abiodun Emmanuel Akinwuntan ◽

Hannes Devos ◽

Kelly Baker ◽

Kendra Phillips ◽

Vibha Kumar ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Driving Skills ◽

Relapsing Remitting ◽

Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up

Journal of Interferon Research ◽

10.1089/jir.1993.13.333 ◽

1993 ◽

Vol 13 (5) ◽

pp. 333-340 ◽

Cited By ~ 69

Author(s):

R.L. KNOBLER ◽

J.I. GREENSTEIN ◽

K.P. JOHNSON ◽

F.D. LUBLIN ◽

H.S. PANITCH ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Human Interferon ◽

Study Analysis ◽

Interferon Β ◽

Relapsing Remitting ◽

Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study

PLoS ONE ◽

10.1371/journal.pone.0165415 ◽

2017 ◽

Vol 12 (7) ◽

pp. e0165415 ◽

Cited By ~ 4

Author(s):

Doriana Landi ◽

Maria Albanese ◽

Fabio Buttari ◽

Fabrizia Monteleone ◽

Laura Boffa ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Interferon Beta ◽

Relapsing Remitting ◽

Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective,  non-randomized pilot study

European Journal of Neurology ◽

10.1111/j.1468-1331.2012.03882.x ◽

2012 ◽

Vol 20 (6) ◽

pp. 986-990 ◽

Cited By ~ 39

Author(s):

E. Portaccio ◽

M. L. Stromillo ◽

B. Goretti ◽

B. Hakiki ◽

A. Giorgio ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Brain Atrophy ◽

Cognitive Changes ◽

Atrophy Rate ◽

Relapsing Remitting ◽

Effects of glatiramer acetate on spasticity in previously interferon-β-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: A prospective, nonrandomized, open-label, uncontrolled, observational pilot study

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.06.005 ◽

2010 ◽

Vol 32 (6) ◽

pp. 1061-1066 ◽

Cited By ~ 10

Author(s):

José Eustasio Meca-Lallana ◽

Pedro de Mingo-Casado ◽

Manuel Amorin-Díaz ◽

María Luisa Martínez-Navarro ◽

Andres Fernández Barreiro

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Glatiramer Acetate ◽

Interferon Β ◽

Open Label ◽

Relapsing Remitting ◽

Treatment Naïve ◽

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.2004.056499 ◽

2005 ◽

Vol 76 (9) ◽

pp. 1294-1296 ◽

Cited By ~ 120

Author(s):

D M Wingerchuk

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Dihydroxyvitamin D3 ◽

1,25 Dihydroxyvitamin D3 ◽

Relapsing Remitting ◽

Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis

Neurological Sciences ◽

10.1007/s10072-006-0561-7 ◽

2006 ◽

Vol 27 (1) ◽

pp. 24-32 ◽

Cited By ~ 21

Author(s):

G. Cavaletti ◽

P. Perseghin ◽

M. Dassi ◽

R. Cavarretta ◽

M. Frigo ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Extracorporeal Photochemotherapy ◽

Relapsing Remitting ◽

Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study

BMC Neurology ◽

10.1186/s12883-016-0595-2 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 22

Author(s):

J. C. Bertoglio ◽

M. Baumgartner ◽

R. Palma ◽

E. Ciampi ◽

C. Carcamo ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Andrographis Paniculata ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases

Frontiers in Neurology ◽

10.3389/fneur.2018.00686 ◽

2018 ◽

Vol 9 ◽

Author(s):

Oliver Findling ◽

Heiko Rust ◽

Özgür Yaldizli ◽

Dionne P. H. Timmermans ◽

Alja Scheltinga ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Relapsing Remitting ◽